Values as of: 2025-05-06
COMMON STOCK | REIT - Healthcare Facilities |
Last Closing
USD 150.5Change
-0.43 (-0.28)%Market Cap
USD 92.95BVolume
2.53MVerdict
Verdict
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| VTR | Ventas Inc |
N/A |
USD 29.73B |
| DOC | Healthpeak Properties Inc |
N/A |
USD 13.10B |
| CTRE | CareTrust REIT Inc. |
N/A |
USD 5.46B |
| AHR | American Healthcare REIT, Inc. |
N/A |
USD 5.17B |
| NHI | National Health Investors Inc |
N/A |
USD 3.54B |
| LTC | LTC Properties Inc |
N/A |
USD 1.55B |
| UHT | Universal Health Realty Income.. |
N/A |
USD 0.53B |
| CHCT | Community Healthcare Trust Inc |
N/A |
USD 0.45B |
| GMRE-PA | Global Medical REIT Inc |
N/A |
USD 0.40B |
| GMRE | Global Medical REIT Inc |
N/A |
N/A |
| Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 19.42% | 93% | A | 94% | A | ||
| Dividend Return | 0.53% | 7% | C- | 24% | F | ||
| Total Return | 19.95% | 94% | A | 94% | A | ||
| Trailing 12 Months | |||||||
| Capital Gain | 54.42% | 93% | A | 96% | N/A | ||
| Dividend Return | 2.69% | 13% | F | 50% | F | ||
| Total Return | 57.11% | 93% | A | 96% | N/A | ||
| Trailing 5 Years | |||||||
| Capital Gain | 258.33% | 100% | F | 92% | A | ||
| Dividend Return | 29.48% | 31% | F | 71% | C- | ||
| Total Return | 287.81% | 100% | F | 92% | A | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 23.52% | 100% | F | 86% | B+ | ||
| Dividend Return | 26.71% | 100% | F | 87% | B+ | ||
| Total Return | 3.20% | 20% | F | 65% | D | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 28.09% | 33% | F | 34% | F | ||
| Risk Adjusted Return | 95.09% | 93% | A | 93% | A | ||
| Market Capitalization | 92.95B | 100% | F | 98% | N/A | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers median on a price to book value basis.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company has under performed its peers on annual average total returns in the past 5 years.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
This stock has shown below median earnings growth in the previous 5 years compared to its sector
